Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 3 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
Superinvestors holding KURA, Q2 2026
No superinvestor reported holding KURA in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of KURA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q3 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)